{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:55:42Z","timestamp":1697432142339},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/bf02983539","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T10:32:26Z","timestamp":1225967546000},"page":"85-91","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hemopoietic Recovery and Infectious Complications in Breast Cancer and Multiple Myeloma after Autologous CD34+ Cell-Selected Peripheral Blood Progenitor Cell Transplantation"],"prefix":"10.1007","volume":"79","author":[{"given":"Luca","family":"De Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Anghel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annino","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Majolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,1,1]]},"reference":[{"key":"BF02983539_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.bmt.1701055","volume":"21","author":"G Schiller","year":"1998","unstructured":"Schiller G, Vescio R, Freytes C, et al. Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma.Bone Marrow Transplant. 1998;21:141\u2013145.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983539_CR2","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1182\/blood.V95.7.2234","volume":"95","author":"RM Lemoli","year":"2000","unstructured":"Lemoli RM, Martinelli G, Zamagni E, et al. Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were infused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.Blood. 2000;95:2234\u20132239.","journal-title":"Blood."},{"key":"BF02983539_CR3","first-page":"1858","volume":"93","author":"R Vescio","year":"1999","unstructured":"Vescio R, Schiller G, Stewart AK, et al. Multicenter phase III trial to evaluate CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.Blood. 1999;93:1858\u20131868.","journal-title":"Blood."},{"key":"BF02983539_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1200\/JCO.1997.15.5.1870","volume":"15","author":"KH Antman","year":"1997","unstructured":"Antman KH, Rowlings PA, Vaugham PW, et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.J Clin Oncol. 1997;15:1870\u20131897.","journal-title":"J Clin Oncol."},{"key":"BF02983539_CR5","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood.V90.11.4313","volume":"90","author":"EJ Shpall","year":"1997","unstructured":"Shpall EJ, LeMaistre CF, Holland K, et al. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer receiving high-dose chemotherapy.Blood. 1997;90:4313\u20134320.","journal-title":"Blood."},{"key":"BF02983539_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/sj.bmt.1700981","volume":"20","author":"D Nachbaur","year":"1997","unstructured":"Nachbaur D, Fink FM, Nussbaumer W, Gachter A, Krophofer G, Ludescher C. CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors: a single-centre experience.Bone Marrow Transplant. 1997;20:827\u2013834.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983539_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1046\/j.1365-2141.1999.01171.x","volume":"104","author":"MT Voso","year":"1999","unstructured":"Voso MT, Hohaus S, Moos M, et al. Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content.Br J Haematol. 1999;104:382\u2013391.","journal-title":"Br J Haematol."},{"key":"BF02983539_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1365-2141.2000.01824.x","volume":"108","author":"S Rutella","year":"2000","unstructured":"Rutella S, Rumi C, Laurenti L, et al. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants.Br J Haematol. 2000;108:105\u2013115.","journal-title":"Br J Haematol."},{"key":"BF02983539_CR9","first-page":"667","volume":"86","author":"M Nishio","year":"2001","unstructured":"Nishio M, Koizumi K, Endo T, Fujimoto K, Koike T, Sawada K. Diminished T-cell recovery after CD34 selected autologous peripheral blood stem cell transplantation increases the risk of cytomegalovirus infection.Haematologica. 2001;86:667\u2013668.","journal-title":"Haematologica."},{"key":"BF02983539_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1089\/152581602321080673","volume":"11","author":"M Lalle","year":"2002","unstructured":"Lalle M, De Rosa L, Pandolfi A, et al. Immune recovery in breast cancer patients after tandem high-dose chemotherapy rescued by selected CD34+ cells.J Hematother Stem Cell Res. 2002;11:983\u2013986.","journal-title":"J Hematother Stem Cell Res."},{"key":"BF02983539_CR11","first-page":"193","volume":"70","author":"M Takeshima","year":"1999","unstructured":"Takeshima M, Takamatsu H, Iida M, Mochizuki Y, Okumura H, Yoshida T. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation.Int J Hematol. 1999;70:193\u2013199.","journal-title":"Int J Hematol."},{"key":"BF02983539_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/152581699320144","volume":"8","author":"M Goerner","year":"1999","unstructured":"Goerner M, Wandt H, Schafer-Eckart K, Birkmann J, Denzel T, Gallmeier WM. The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.J Hematother Stem Cell Res. 1999;8:387\u2013391.","journal-title":"J Hematother Stem Cell Res."},{"key":"BF02983539_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1046\/j.1365-2141.1998.00572.x","volume":"100","author":"T Miyamoto","year":"1998","unstructured":"Miyamoto T, Gondo H, Miyoshi Y, et al. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin\u2019s lymphoma.Br J Haematol. 1998;100;348\u2013350.","journal-title":"Br J Haematol."},{"key":"BF02983539_CR14","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","volume":"94","author":"LA Holmberg","year":"1999","unstructured":"Holmberg LA, Boeckh M, Hooper H, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.Blood. 1999;94:4029\u20134035.","journal-title":"Blood."},{"key":"BF02983539_CR15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/blood.V96.3.1194","volume":"96","author":"GJ Schiller","year":"2000","unstructured":"Schiller GJ, Vescio R, Berenson J. Cytomegalovirus infection following transplantation of autologous CD34-selected progenitor cells [letter].Blood. 2000;96:1194.","journal-title":"Blood."},{"key":"BF02983539_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.bmt.1700826","volume":"19","author":"D Nachbaur","year":"1997","unstructured":"Nachbaur D, Kropshoffer G, Feichtinger H, Allerberger F, Niederweiser D. Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBPCT): treatment with paramomycin, azithromycin and recombinant human interleukin-2.Bone Marrow Transplant. 1997;19:1261\u20131263.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983539_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/bbmt.2002.v8.pm12064366","volume":"8","author":"FL Crippa","year":"2002","unstructured":"Crippa FL, Holmberg L, Carter RA, et al. Infectious complications after autologous CD34-selected peripheral blood progenitor cell transplantation.Biol Blood Marrow Transplant. 2002;8:281\u2013289.","journal-title":"Biol Blood Marrow Transplant."},{"key":"BF02983539_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/sj.bmt.1702623","volume":"26","author":"J Friedman","year":"2000","unstructured":"Friedman J, Lazarus HM, Koc ON. Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation.Bone Marrow Transplant. 2000;26:831\u2013836.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983539_CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.V96.1.369","volume":"96","author":"KS Peggs","year":"2000","unstructured":"Peggs KS, Ings SJ, Kotlaridis PD, et al. Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring [letter].Blood. 2000;96:369\u2013370.","journal-title":"Blood."},{"key":"BF02983539_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF02982008","volume":"74","author":"S Maeda","year":"2001","unstructured":"Maeda S, Kagami Y, Ogura M, et al. CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications.Int J Hematol. 2001;74:214\u2013221.","journal-title":"Int J Hematol."},{"key":"BF02983539_CR21","first-page":"449","volume":"377","author":"RJ Berenson","year":"1992","unstructured":"Berenson RJ, Bensinger WI, Kalamasz DF, et al. Transplantation of stem cells enriched by immunoadsorption.Prog Clin Biol Res. 1992;377:449\u2013457.","journal-title":"Prog Clin Biol Res."},{"key":"BF02983539_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/sj.bmt.1701257","volume":"21","author":"SD Rowley","year":"1997","unstructured":"Rowley SD, Loken M, Radich J, et al. Isolation of CD34+ cells from blood stem cells components using the Baxter Isolex system.Bone Marrow Transplant. 1997;21:1253\u20131262.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983539_CR23","first-page":"399","volume":"12","author":"P Ljungman","year":"1993","unstructured":"Ljungman P, De Bock R, Cordonnier C, et al. Practices of cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.Bone Marrow Transplant. 1993;12:399\u2013403.","journal-title":"Bone Marrow Transplant"},{"key":"BF02983539_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.bmt.1703244","volume":"28","author":"AK Blystad","year":"2001","unstructured":"Blystad AK, Holte H, Kvaloy S, Smeland E, Delabie J, Kvalheim G. High-dose therapy in patients with Hodgkin\u2019s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells.Bone Marrow Transplant. 2001;28:849\u2013857.","journal-title":"Bone Marrow Transplant."},{"issue":"suppl 1","key":"BF02983539_CR25","first-page":"A5","volume":"77","author":"S Martin","year":"1998","unstructured":"Martin S, Voso MT, Hohaus S, Ho AD, Haas R. The time to hematopoietic reconstitution following high-dose therapy in cancer patients is related to the number of CD34+ cells transplanted, diagnosis and type of conditioning regimen.Ann Hematol. 1998;77(suppl 1):A5.","journal-title":"Ann Hematol."},{"key":"BF02983539_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s002770000218","volume":"79","author":"O Sezer","year":"2000","unstructured":"Sezer O, Eucker J, Bauhuis C, Schweigert M, Luftner D, Kalus U. Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high- dose chemotherapy with autologous peripheral stem cell transplantation.Ann Hematol. 2000;79:627\u2013630.","journal-title":"Ann Hematol."},{"key":"BF02983539_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bmt.1702822","volume":"27","author":"G Reich","year":"2001","unstructured":"Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors.Bone Marrow Transplant. 2001;27:525\u2013529.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983539_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1086\/318491","volume":"32","author":"TD Barton","year":"2001","unstructured":"Barton TD, Collis T, Stadtmauer EA, Schuster MG. Infectious complications after autologous bone marrow transplantation for treatment of breast cancer.Clin Infect Dis. 2001;32:391\u2013395.","journal-title":"Clin Infect Dis."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02983539\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T23:04:43Z","timestamp":1589065483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02983539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF02983539"],"URL":"https:\/\/doi.org\/10.1007\/bf02983539","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}